Lloyds Enterprises Limited has announced the approval of a grant for 1,35,440 Employee Stock Options. These options are convertible into an equal number of equity shares of the company at a face value of Re. 1/- each. The grant, approved by the Nomination and Remuneration Committee on 19th October 2026, is under the company’s Employee Stock Option Plan – 2025, with an exercise price of Rs. 2/- per option.
Employee Stock Option Grant Approved
Lloyds Enterprises Limited has officially approved the grant of a significant number of Employee Stock Options (ESOPs) under its designated stock option plan. The Nomination and Remuneration Committee of the Board, through a circular resolution passed on 19th October 2026, sanctioned the issuance of 1,35,440 Employee Stock Options. These options are set to be convertible into an equal number of equity shares of the company, each with a face value of Re. 1/-.
Scheme Details and Exercise Terms
The ESOPs fall under the purview of the Lloyds Enterprises Limited Employee Stock Option Plan – 2025, referred to as the “Scheme.” This grant is in compliance with the SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021. The exercise price for each stock option has been determined at Rs. 2/-. While the options are granted, the vesting and exercise periods will be detailed in individual grant letters, with a minimum vesting period of one year from the date of grant. The exercise period for vested options will be three years from the respective vesting date.
Disclosure and Availability
The company has made detailed disclosures regarding this grant, as required by Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further information, including the brief details of significant terms and the vesting schedule, is available in Annexure – A, which is attached to the official communication. The details are also accessible on the company’s website at www.lloydsenterprises.in.
Source: BSE
